10x Genomics, Inc.

SEC 8-K · Filed

0001628280-25-052154Accepted

Applies to the EDGAR acceptance time.

Other time zone
Leadership changesItem 5.02Effective date Jan 1, 2026

Randy Wu — appointed as General Counsel and Secretary

has been appointed to succeed Mr. Whitaker as General Counsel and Secretary of the Company effective January 1, 2026
Structured facts
{
  "action": "appointed",
  "evidence": "has been appointed to succeed Mr. Whitaker as General Counsel and Secretary of the Company effective January 1, 2026",
  "person": "Randy Wu",
  "role": "General Counsel and Secretary"
}
Leadership changesItem 5.02Effective date Jan 1, 2026Announced Nov 12, 2025

Eric S. Whitaker — announced as Strategic Counsel

Mr. Whitaker will remain an employee of the Company with reduced compensation and assume the position of Strategic Counsel
Structured facts
{
  "action": "appointed",
  "announced_on": "2025-11-12",
  "evidence": "Mr. Whitaker will remain an employee of the Company with reduced compensation and assume the position of Strategic Counsel",
  "person": "Eric S. Whitaker",
  "role": "Strategic Counsel",
  "state": "announced"
}
Leadership changesItem 5.02Effective date Jan 1, 2026Announced Nov 12, 2025

Eric S. Whitaker — announced departure from the Chief Legal Officer role

Eric S. Whitaker announced his intention to retire as Chief Legal Officer of 10x Genomics, Inc.
Structured facts
{
  "action": "departed",
  "announced_on": "2025-11-12",
  "evidence": "Eric S. Whitaker announced his intention to retire as Chief Legal Officer of 10x Genomics, Inc.",
  "person": "Eric S. Whitaker",
  "role": "Chief Legal Officer",
  "state": "announced"
}